Skip to content

Clinical trials

Phase 2/3 Breast Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2/3 Country / region: China Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20091
20101
20111
20125
20161
20174
20182
20191
20203
20212
20221
20233
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14
Recruiting8
Active, not recruiting4
Completed4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital4
Tianjin Medical University4
Fudan University3
Hebei Medical University Fourth Hospital3
Guangdong Provincial People's Hospital2
Shanghai Pharmaceuticals Holding Co., Ltd2
Tianjin Medical University Cancer Institute and Hospital2
Bristol-Myers Squibb1
Chinese Academy of Medical Sciences1
Chinese PLA General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms31
Triple Negative Breast Neoplasms2
Breast Diseases1
Carcinoma, Hepatocellular1
Colonic Neoplasms1
Diarrhea1
Head and Neck Neoplasms1
Kidney Neoplasms1
Lung Neoplasms1
Melanoma1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.